Victory Capital Management
FBIO icon

Victory Capital Management’s Fortress Biotech FBIO Stock Holding History

Victory Capital Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-677
Closed -$5.58K – 2530
2023
Q2 		$5.58K Buy
+677
New +$6.7K ﹤0.01% 2496
2022
Q4 		– Sell
-693
Closed -$9K – 2626
2022
Q3 		$9K Sell
693
-92
-12% -$1.38K ﹤0.01% 2664
2022
Q2 		$10K Buy
785
+52
+7% +$771 ﹤0.01% 2650
2022
Q1 		$12K Sell
733
-21
-3% -$575 ﹤0.01% 2669
2021
Q4 		$28K Sell
754
-44
-6% -$1.96K ﹤0.01% 2673
2021
Q3 		$39K Buy
798
+1
+0.1% +$49 ﹤0.01% 2701
2021
Q2 		$43K Buy
797
+46
+6% +$2.77K ﹤0.01% 2673
2021
Q1 		$40K Sell
751
-76
-9% -$4.29K ﹤0.01% 2682
2020
Q4 		$39K Buy
827
+100
+14% +$4.33K ﹤0.01% 2473
2020
Q3 		$44K Buy
727
+24
+3% +$1.22K ﹤0.01% 2394
2020
Q2 		$28K Buy
703
+8
+1% +$297 ﹤0.01% 2427
2020
Q1 		$20K Buy
+695
New +$23.1K ﹤0.01% 2839
2019
Q4 		– Sell
-517
Closed -$11K – 2848
2019
Q3 		$11K Buy
+517
New +$12.2K ﹤0.01% 3225

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Victory Capital Management's FBIO Position: Q3 2023 in Review

Victory Capital Management sold out of Fortress Biotech (FBIO) in Q3 2023, closing a stake of 677 shares — an estimated $5.58K sold.

Victory Capital Management first reported a position in FBIO in Q3 2019 and held it in 13 quarters. The position peaked at $44K in Q3 2020. 48 funds tracked by Wall St. Rank hold FBIO as of Q3 2023.

  • Victory Capital Management reported no remaining Fortress Biotech position as of Q3 2023 after selling out during the quarter.
  • Victory Capital Management sold 677 Fortress Biotech shares in Q3 2023, an estimated $5.58K.
  • Victory Capital Management first reported a position in Fortress Biotech in Q3 2019 and held it in 13 quarters.
  • Victory Capital Management's Fortress Biotech position peaked at $44K in Q3 2020.
  • 48 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2023.

Based on Victory Capital Management's 13F filing for Q3 2023, filed 6 Nov 2023.